Herein, we sought to construct risk calculators based on cancer biomarkers, enabling more accurate discrimination among patients which may benefit from active interventions.Ki67 immunoscore, GSTP1 and KLF8 promoter methylation levels (<sup>me</sup>) were assessed in PCa tissues. Here, KLF8 is linked to posterior cortical atrophy.